methenamine has been researched along with Cancer of Prostate in 2 studies
Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luna-Moré, S | 1 |
| Genster, HG | 1 |
| Madsen, PO | 1 |
2 other studies available for methenamine and Cancer of Prostate
| Article | Year |
|---|---|
Argyrophil crystalloids in adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Alcian Blue; Amylases; Carcinoma in Situ; Eosine Yellowish-(YS); Hematoxylin; | 1993 |
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Ceph | 1970 |